<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661856</url>
  </required_header>
  <id_info>
    <org_study_id>0012254</org_study_id>
    <nct_id>NCT00661856</nct_id>
  </id_info>
  <brief_title>Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices</brief_title>
  <acronym>SoyPTI</acronym>
  <official_title>The Effect of Increased Soy Protein Intake on Bone Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Solae, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study was to investigate the effects of soy and soy plus isoflavones
      on bone mineral Density and physical performance in post menopausal women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post menopausal estrogen deficiency causes physiologic changes in body composition including
      decreased lean body weight and bone mass. A decrease in muscle strength along with
      osteoporosis puts post menopausal women at a high risk of hip fractures causing considerable
      mortality and morbidity. Estrogen use has been shown to reduce bone density loss and increase
      muscle strength but given the concerns regarding its use, patients are looking for
      alternatives such as Soy isoflavones. Most human studies on the effect of Soy on bone mineral
      density (BMD) in post menopausal women have been short term i.e. 3-6 months and failed to
      provide conclusive evidence. There is no evidence of its effects on physical performance.

      The aim of the present study is to investigate the effects of 25g of soy protein alone or
      with 90mg of isoflavones on bone mineral Density and physical performance indices in post
      menopausal women over a duration of 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2001</start_date>
  <completion_date type="Actual">January 2004</completion_date>
  <primary_completion_date type="Actual">January 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Performance Indices</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">203</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Soy Protein group 25g of Soy protein with no Isoflavones</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Soy Isoflavone group 25g of Soy Protein with 90mg of Isoflavones</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>25g of Milk protein</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soy protein</intervention_name>
    <description>25g of Soy protein with or with out 90mg of isoflavones ones a day given for a period of 24 months</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>genistein, daidzein, glycetein</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 55-75 years of age

          -  at least 7 years post menopausal either spontaneous or surgical

        Exclusion Criteria:

          -  must not have used estrogen for atleast 2 months prior to entering study

          -  must be on no bone active drugs such as bisphosphonates, anti convulsants, calcitonin
             and long term steroids

          -  osteoporosis (T-score&lt;-2.5)

          -  BMI &lt;18 or &gt;34
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J C Gallagher</last_name>
    <role>Principal Investigator</role>
    <affiliation>Creighton University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Creighton University Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause. 2004 May-Jun;11(3):290-8.</citation>
    <PMID>15167308</PMID>
  </reference>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2008</study_first_submitted>
  <study_first_submitted_qc>April 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2008</study_first_posted>
  <last_update_submitted>April 17, 2008</last_update_submitted>
  <last_update_submitted_qc>April 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>J C Gallagher</name_title>
    <organization>Creighton University Medical Center</organization>
  </responsible_party>
  <keyword>Soy Isoflavones, Bone Mineral Density, Post menopausal women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

